Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.

Babikir KheiriSunil V RaoMohammed OsmanTimothy F SimpsonMahmoud BarbarawiYazan ZayedHarsukh N DhillonMohamad AlkhouliHarsh GolwalaFiras E ZahrDeepak L BhattGregg W StoneJoaquin E Cigarroa

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)

Among patients undergoing TRI, use of bivalirudin was associated with significantly reduced 30-day NACE compared with heparin. There was no significant difference in long term NACE, ischemic, or bleeding events compared with heparin.

Keyphrases

percutaneous coronary intervention
venous thromboembolism
patients undergoing
systematic review
growth factor
coronary artery disease
coronary artery
atrial fibrillation
acute coronary syndrome
physical activity
meta analyses
transcatheter aortic valve replacement
cerebral ischemia
aortic stenosis